Literature DB >> 19659630

Catheter ablation of atrial fibrillation in the elderly.

Takumi Yamada1, G Neal Kay.   

Abstract

The incidence and prevalence of atrial fibrillation (AF) increase with age. Catheter ablation has been suggested to improve the quality of life of patients with AF. However, in order to expand the indications for AF ablation to the elderly, several important questions should be answered as to whether safety and efficacy of AF ablation in elderly patients are similar to those in younger populations, whether the AF mechanisms in elderly patients are similar to those in younger patients so that the same ablation techniques can be used in both groups, and whether anticoagulation strategies should be the same for elderly patients as for younger patients after AF ablation. Recent studies reported that the risk of complications from AF ablation did not vary with age, nor was the AF recurrence rate age-dependent for any type of AF, suggesting that the AF mechanisms in elderly patients were similar to those in younger patients. On the other hand, the feasibility of discontinuation of anticoagulation in the elderly after successful AF ablation has not been established since it is difficult to be certain whether AF has been truly cured and since many elderly people are likely to be considered as high-risk based on their CHADS(2) score. In addition, the elderly patients who have been included in published trials of AF ablation may not represent an unselected population of individuals in this age group. Randomized trials of catheter ablation will be necessary before this procedure can be promoted for wider use in the elderly.

Entities:  

Mesh:

Year:  2009        PMID: 19659630     DOI: 10.1111/j.1540-8159.2009.02442.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Deep sedation during catheter ablation for atrial fibrillation in elderly patients.

Authors:  Alexander Wutzler; Lena Loehr; Martin Huemer; Abdul Shokor Parwani; Elisabeth Steinhagen-Thiessen; Leif-Hendrik Boldt; Wilhelm Haverkamp
Journal:  J Interv Card Electrophysiol       Date:  2013-09-08       Impact factor: 1.900

Review 2.  Ablation of Atrial Fibrillation in the Elderly: Current Evidence and Evolving Trends.

Authors:  Suraj Kapa; Rupa Bala
Journal:  J Atr Fibrillation       Date:  2011-07-15

Review 3.  Impact of Metabolic Syndrome on Ablation-Outcome in Patients with Atrial Fibrillation: A Systematic Review.

Authors:  Sanghamitra Mohanty; Luigi Di Biase; Prasant Mohanty; Pasquale Santangeli; Bai Rong; Trivedy Chintan; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2013-02-12

Review 4.  Catheter Ablation Of Atrial Fibrillation In The Elderly: Risk Benefit Analysis.

Authors:  Samet Yılmaz M D; Ugur Canpolat M D
Journal:  J Atr Fibrillation       Date:  2014-08-31

5.  Catheter ablation of atrial fibrillation in the elderly.

Authors:  Louiza Lioni; Konstantinos P Letsas; Michael Efremidis; Konstantinos Vlachos; Georgios Giannopoulos; Vasileios Kareliotis; Spyridon Deftereos; Antonios Sideris
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

6.  Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.

Authors:  Noémi Klára Tóth; Zoltán Csanádi; Orsolya Hajas; Alexandra Kiss; Edina Nagy-Baló; Kitti Bernadett Kovács; Ferenc Sarkady; László Muszbek; Zsuzsanna Bereczky; László Csiba; Zsuzsa Bagoly
Journal:  Biomed Res Int       Date:  2017-06-21       Impact factor: 3.411

7.  The effect of concomitant chronic kidney disease on the recurrence of atrial fibrillation after catheter ablation: A protocol for systematic review and meta-analysis.

Authors:  Xiaodong Liu; Dapeng Wang; Bo Tang; Xiuying Lv
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 8.  Managing atrial fibrillation in the very elderly patient: challenges and solutions.

Authors:  Nikolaos Karamichalakis; Konstantinos P Letsas; Konstantinos Vlachos; Stamatis Georgopoulos; Athanasios Bakalakos; Michael Efremidis; Antonios Sideris
Journal:  Vasc Health Risk Manag       Date:  2015-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.